Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia

Curr Neurovasc Res. 2012 Aug;9(3):185-92. doi: 10.2174/156720212801619018.

Abstract

Activated platelets shed microparticles, which contain a variety of growth factors central to angiogenesis and neurogenesis. The aim of this study was to explore whether platelet derived microparticles (PMP) can boost endogenous neural stem cells dependent repair mechanisms following stroke in a rat model. To examine the effects of PMP therapy in-vivo, we delivered PMP or vehicle via a biodegradable polymer to the brain surface after permanent middle cerebral artery occlusion (PMCAO) in rats. Rats were tested with the neurological severity score and infarct volumes were measured at 90 days post-ischemia. Immunohistochemistry was used to determine the fate of newborn cells and to count blood vessels in the ischemic brain. The results show that PMP led to a dose dependent increase in cell proliferation, neurogenesis and angiogenesis at the infarct boundary zone and significantly improved behavioral deficits.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Blood Platelets / chemistry*
  • Blood Platelets / cytology
  • Brain Ischemia / etiology
  • Brain Ischemia / therapy*
  • Bromodeoxyuridine / metabolism
  • Cell Count
  • Cell Differentiation / drug effects
  • Cell-Derived Microparticles / physiology*
  • Disability Evaluation
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Infarction, Middle Cerebral Artery / complications
  • Neovascularization, Physiologic / drug effects
  • Neovascularization, Physiologic / physiology*
  • Nerve Tissue Proteins / metabolism
  • Neural Stem Cells / drug effects
  • Neural Stem Cells / physiology
  • Neurogenesis / drug effects
  • Neurogenesis / physiology*
  • Rats
  • Rats, Inbred SHR
  • Recovery of Function
  • Time Factors

Substances

  • Nerve Tissue Proteins
  • Bromodeoxyuridine